Drug	Gene	Type	Source
cytarabine	TDP1	Potency=0.0366(uM)	D1 PubChem
cytarabine	TDP1	Potency=0.0411(uM)	D1 PubChem
cytarabine	TDP1	Potency=0.0944(uM)	D1 PubChem
cytarabine	TDP1	Potency=0.1189(uM)	D1 PubChem
cytarabine	TP53	Potency=0.1536(uM)	D1 PubChem
cytarabine	TP53	Ratio Potency (uM)=0.318365(uM)	D1 PubChem
cytarabine	TP53	Potency=0.4216(uM)	D1 PubChem
cytarabine	TP53	Ratio Potency (uM)=0.794208(uM)	D1 PubChem
cytarabine	NCOA3	IC50=7.533(uM)	D1 PubChem
cytarabine	AR	Ratio Potency (uM)=7.76062(uM)	D1 PubChem
cytarabine	CYP2C9	-	D1 PubChem
cytarabine	BRCA1	-	D1 PubChem
cytarabine	POLA1	-	D1 PubChem
cytarabine	POLD1	-	D1 PubChem
cytarabine	CYP2C19	-	D1 PubChem
cytarabine	CYP2D6	-	D1 PubChem
cytarabine	MDM4	-	D1 PubChem
cytarabine	MDM2	-	D1 PubChem
cytarabine	CYP3A4	-	D1 PubChem
cytarabine	POLE	-	D1 PubChem
cytarabine	JAK2	-	D1 PubChem
cytarabine	CYP1A2	-	D1 PubChem
cytarabine	BARD1	-	D1 PubChem
cytarabine	CYP3A4	Inhibition=None(Unspecified)	D1 ChEMBL
cytarabine	CYP2C9	Inhibition=None(Unspecified)	D1 ChEMBL
cytarabine	CYP2C19	Inhibition=None(Unspecified)	D1 ChEMBL
cytarabine	CYP2D6	Inhibition=None(Unspecified)	D1 ChEMBL
cytarabine	CYP1A2	Inhibition=None(Unspecified)	D1 ChEMBL
cytarabine	NCOA3	IC50=7533.0(nM)	D1 ChEMBL
cytarabine	EHMT2	Potency=11220.2(nM)	D1 ChEMBL